Zobrazeno 1 - 10
of 1 565
pro vyhledávání: '"Horlings, A."'
Autor:
Goertzel, Ben, Bogdanov, Vitaly, Duncan, Michael, Duong, Deborah, Goertzel, Zarathustra, Horlings, Jan, Ikle', Matthew, Meredith, Lucius Greg, Potapov, Alexey, de Senna, Andre' Luiz, Suarez, Hedra Seid Andres, Vandervorst, Adam, Werko, Robert
An introduction to the OpenCog Hyperon framework for Artificiai General Intelligence is presented. Hyperon is a new, mostly from-the-ground-up rewrite/redesign of the OpenCog AGI framework, based on similar conceptual and cognitive principles to the
Externí odkaz:
http://arxiv.org/abs/2310.18318
Autor:
Walker, Cedric, Talawalla, Tasneem, Toth, Robert, Ambekar, Akhil, Rea, Kien, Chamian, Oswin, Fan, Fan, Berezowska, Sabina, Rottenberg, Sven, Madabhushi, Anant, Maillard, Marie, Barisoni, Laura, Horlings, Hugo Mark, Janowczyk, Andrew
The discovery of patterns associated with diagnosis, prognosis, and therapy response in digital pathology images often requires intractable labeling of large quantities of histological objects. Here we release an open-source labeling tool, PatchSorte
Externí odkaz:
http://arxiv.org/abs/2307.07528
Autor:
Cédric Walker, Tasneem Talawalla, Robert Toth, Akhil Ambekar, Kien Rea, Oswin Chamian, Fan Fan, Sabina Berezowska, Sven Rottenberg, Anant Madabhushi, Marie Maillard, Laura Barisoni, Hugo Mark Horlings, Andrew Janowczyk
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-7 (2024)
Abstract The discovery of patterns associated with diagnosis, prognosis, and therapy response in digital pathology images often requires intractable labeling of large quantities of histological objects. Here we release an open-source labeling tool, P
Externí odkaz:
https://doaj.org/article/887f336880b34a1995344eabcbd97700
Autor:
M. C. Liefaard, A. van der Voort, M. van Seijen, B. Thijssen, J. Sanders, S. Vonk, L. Mittempergher, R. Bhaskaran, L. de Munck, A. E. van Leeuwen-Stok, R. Salgado, H. M. Horlings, E. H. Lips, G. S. Sonke
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Tumor-infiltrating lymphocytes (TILs) have been associated with outcomes in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy and trastuzumab. However, it remains unclear if TILs could be a prognostic and/or predicti
Externí odkaz:
https://doaj.org/article/dfc1b1ee02aa46cab23090ed7177554b
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Autor:
Mark Opdam, Annelot G.J. van Rossum, Marlous Hoogstraat, Gergana Bounova, Hugo M. Horlings, Erik van Werkhoven, Ingrid A.M. Mandjes, A. Elise van Leeuwen – Stok, Sander Canisius, Harm van Tinteren, Alex L.T. Imholz, Johanneke E.A. Portielje, Monique E.M.M. Bos, Sandra Bakker, Jelle Wesseling, Lennart Kester, Jacco van Rheenen, Emiel J. Rutgers, Renee X. de Menezes, Lodewyk F.A. Wessels, Marleen Kok, Hendrika M. Oosterkamp, Sabine C. Linn, Marcel Soesan, Rianne M. Oosterkamp, Frank Jeurissen, Nir Weijl, Karin J. Beelen, Aart van Bochove, Gerty de Klerk, Suzan Vrijaldenhoven, Annette van der Velden, Hiltje de Graaf, Marielle Smeets, Jetske Meerum Terwogt, Jolanda Schrama, Philomeen Kuijer, Hanneke Wilmink, Ronald Hoekstra, Judith Kroep, Hans F.M. Pruijt, Leander van Gerven, Allert H. Vos, Frans Erdkamp, Willemien G. van Leeuwen-Breuk, Alexander de Graeff
Publikováno v:
iScience, Vol 27, Iss 8, Pp 110425- (2024)
Summary: The primary objective of the prospective, randomized, multicenter, phase 3 biomarker Microarray Analysis in breast cancer to Taylor Adjuvant Drugs Or Regimens trial (MATADOR: ISRCTN61893718) is to generate a gene expression profile that can
Externí odkaz:
https://doaj.org/article/3dae747c44804a5fafa1281b33a3c21c
Autor:
Deenen, Johanna C.W., Horlings, Corinne G.C., Voermans, Nicol C., van Doorn, Pieter A., Faber, Catharina G., van der Kooi, Anneke J., Kuks, Jan B.M., Notermans, Nicolette C., Visser, Leo H., Broekgaarden, Ria H.A., Horemans, Anja M.C., Verschuuren, Jan J.G.M., Verbeek, André L.M., van Engelen, Baziel G.M.
Publikováno v:
In Neuromuscular Disorders September 2024 42:27-35
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Autor:
Linn, Sabine C., Soesan, Marcel, Oosterkamp, Rianne M., Jeurissen, Frank, Weijl, Nir, Imholz, Alex L.T., Portielje, Johanneke E.A., Beelen, Karin J., Bos, Monique E.M.M., van Bochove, Aart, de Klerk, Gerty, Vrijaldenhoven, Suzan, van der Velden, Annette, de Graaf, Hiltje, Smeets, Marielle, Terwogt, Jetske Meerum, Schrama, Jolanda, Kuijer, Philomeen, Wilmink, Hanneke, Hoekstra, Ronald, Kroep, Judith, Pruijt, Hans F.M., van Gerven, Leander, Vos, Allert H., Erdkamp, Frans, van Leeuwen-Breuk, Willemien G., de Graeff, Alexander, Opdam, Mark, van Rossum, Annelot G.J., Hoogstraat, Marlous, Bounova, Gergana, Horlings, Hugo M., van Werkhoven, Erik, Mandjes, Ingrid A.M., van Leeuwen – Stok, A. Elise, Canisius, Sander, van Tinteren, Harm, Bakker, Sandra, Wesseling, Jelle, Kester, Lennart, van Rheenen, Jacco, Rutgers, Emiel J., de Menezes, Renee X., Wessels, Lodewyk F.A., Kok, Marleen, Oosterkamp, Hendrika M.
Publikováno v:
In iScience 16 August 2024 27(8)
Publikováno v:
In Cities July 2024 150
Autor:
Witali Aswolinskiy, Enrico Munari, Hugo M. Horlings, Lennart Mulder, Giuseppe Bogina, Joyce Sanders, Yat-Hee Liu, Alexandra W. van den Belt-Dusebout, Leslie Tessier, Maschenka Balkenhol, Michelle Stegeman, Jeffrey Hoven, Jelle Wesseling, Jeroen van der Laak, Esther H. Lips, Francesco Ciompi
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background Invasive breast cancer patients are increasingly being treated with neoadjuvant chemotherapy; however, only a fraction of the patients respond to it completely. To prevent overtreatment, there is an urgent need for biomarkers to p
Externí odkaz:
https://doaj.org/article/83850dbe69834722be710c67bd14b3d4
Autor:
Tessa G. Steenbruggen, Denise M. Wolf, Michael J. Campbell, Joyce Sanders, Sten Cornelissen, Bram Thijssen, Roberto A. Salgado, Christina Yau, Nick O-Grady, Amrita Basu, Rajith Bhaskaran, Lorenza Mittempergher, Gillian L. Hirst, Jean-Philippe Coppe, Marleen Kok, Gabe S. Sonke, Laura J. van ‘t Veer, Hugo M. Horlings
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-19 (2023)
Abstract Background Despite major improvements in treatment of HER2-positive metastatic breast cancer (MBC), only few patients achieve complete remission and remain progression free for a prolonged time. The tumor immune microenvironment plays an imp
Externí odkaz:
https://doaj.org/article/cd4ee360474c49639be138517e337159